Specific activin receptor-like kinase 3 inhibitors enhance liver regeneration.
Tsugawa D, Oya Y, Masuzaki R, Ray K, Engers DW, Dib M, Do N, Kuramitsu K, Ho K, Frist A, Yu PB, Bloch KD, Lindsley CW, Hopkins CR, Hong CC, Karp SJ.
Tsugawa D, et al.
J Pharmacol Exp Ther. 2014 Dec;351(3):549-58. doi: 10.1124/jpet.114.216903. Epub 2014 Sep 30.
J Pharmacol Exp Ther. 2014.
PMID: 25271257
Free PMC article.